Related Experiment Video
Updated: Jun 10, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Lung Ultrasound Findings in Pediatric Mycoplasma Pneumoniae Pneumonia: A Prospective Multicenter Pilot Study
Mariantonietta Francavilla1, Azzurra Orlandi2, Anna Camporesi3
1Department of Radiology, Giovanni XXIII Children Hospital, Azienda Ospedaliero Universitaria Consorziale Policlinico, 70126 Bari, Italy.
Insights
Lung ultrasound (LUS) effectively identifies features of Mycoplasma pneumoniae pneumonia in children. This non-invasive imaging can guide personalized treatment for pediatric lower respiratory tract infections.
Area of Science:
- Pediatric Pulmonology
- Medical Imaging
- Infectious Diseases
Background:
- Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children.
- Accurate and timely diagnosis is crucial for effective management and to prevent complications.
- Lung ultrasound (LUS) offers a non-invasive, radiation-free imaging modality for pediatric respiratory conditions.
Purpose of the Study:
- To characterize the lung ultrasound (LUS) features of Mycoplasma pneumoniae pneumonia in pediatric patients.
- To determine the distribution of these LUS findings across different age groups.
- To correlate LUS findings with clinical and laboratory data for improved diagnostic accuracy.
Main Methods:
- A multicenter, prospective pilot study involving 35 pediatric patients diagnosed with Mycoplasma pneumoniae infection.
- Standardized LUS examinations were performed at admission, recording features like consolidation, bronchograms, B lines, and pleural effusion.
- A composite LUS score was calculated based on various imaging parameters.
Main Results:
- Subpleural consolidations were observed in 97% of patients, predominantly in basal, posterior, and lateral lung fields.
- Multiple consolidations were present in 65% of cases; B lines in 43%, and pleural effusion in 37%.
- Patient age correlated with consolidation size, while higher lymphocyte counts were associated with smaller consolidations.
Conclusions:
- Lung ultrasound (LUS) demonstrates characteristic findings suggestive of Mycoplasma pneumoniae pneumonia in children.
- LUS is a valuable, low-cost tool for managing pediatric lower respiratory tract infections, aiding personalized treatment strategies.
- Further comparative studies are needed to validate LUS patterns for pathogen specificity and outcome prediction.
Abstract:
Aims: To describe lung ultrasound (LUS) features of Mycoplasma pneumoniae pneumonia and their distribution in pediatric age, and to correlate imaging findings with clinical and laboratory data. Methods: This is a multicenter, prospective, pilot study that involved three hospitals. In total, 35 patients aged 1 month to 17 years, admitted with a diagnosis of Mycoplasma pneumoniae infection, were enrolled. History, clinical, microbiological, and ultrasound data were collected. The LUS examination was performed at admission, recording the following features: presence of subpleural consolidation, bronchograms, B lines, or pleural effusion, and their characteristics. The scans were performed using a standardized approach, in which a composite score was obtained by summing the scores of the different parameters. Results: Consolidations were seen in 97% of children (mostly located in basal, posterior, and lateral fields), and 65% of patients had multiple ones. Non-perilesional B lines were found in 43% of cases, principally in the posterior and basal fields. Pleural effusion was found in 37% of children. The univariate logistic regression showed a correlation between the age of the patient and large-sized consolidations. Moreover, increased lymphocyte count was associated with a lower risk of large-sized consolidations. Conclusions: LUS is a low-cost, non-invasive tool that can reveal findings suggestive of Mycoplasma pneumoniae infection and help physicians better manage children with lower respiratory tract infections, supporting a more personalized diagnostic and therapeutic approach, including antibiotic selection. These preliminary findings also indicate that a larger, comparative study involving other bacterial and viral etiologic agents is warranted to confirm whether LUS patterns are pathogen-specific and whether they can predict clinical outcomes.

